MedTrace Logo

Accuracy of Endo-aid in Consecutive Patients Referred for Colonoscopy

NCT05862948 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1160

Last updated 2023-05-17

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the diagnostic yield of CADe in a consecutive population undergoing colonoscopy. The main question it aims to answer is the Adenoma Detection Rate (ADR). Participants undergoing colonoscopy will be randomized in a 1:1 ratio to either receive Computer-Aided Detection (CADe) colonoscopy or a conventional colonoscopy (CC). Researchers will compare the CADe group and the CC-group to see if CAD-e can increase the ADR significantly.

Conditions

  • Adenoma Colon
  • Colonic Adenoma

Interventions

DEVICE

ENDO-Aid by Olympus

Colonoscopy assisted by ENDO-AID device

Sponsors & Collaborators

  • Fondazione Poliambulanza Istituto Ospedaliero

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-30
Primary Completion
2023-03-31
Completion
2023-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05862948 on ClinicalTrials.gov